BioCentury
ARTICLE | Clinical News

Basen voglibose regulatory update

December 24, 2007 8:00 AM UTC

Takeda submitted a Japanese marketing application to expand the label for Basen voglibose tablets 0.2 mg and Basen OD tablets 0.2 mg to prevent onset of Type II diabetes in patients with impaired gluc...